KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Invested Capital (2017 - 2022)

Historic Return on Invested Capital for Arbutus Biopharma (ABUS) over the last 6 years, with Q4 2022 value amounting to 0.5%.

  • Arbutus Biopharma's Return on Invested Capital changed N/A to 0.5% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.5%, marking a year-over-year change of. This contributed to the annual value of 0.46% for FY2022, which is N/A changed from last year.
  • Latest data reveals that Arbutus Biopharma reported Return on Invested Capital of 0.5% as of Q4 2022.
  • In the past 5 years, Arbutus Biopharma's Return on Invested Capital registered a high of 0.23% during Q4 2018, and its lowest value of 1.74% during Q1 2020.
  • Over the past 4 years, Arbutus Biopharma's median Return on Invested Capital value was 0.47% (recorded in 2019), while the average stood at 0.79%.
  • As far as peak fluctuations go, Arbutus Biopharma's Return on Invested Capital skyrocketed by 11400bps in 2018, and later plummeted by -14700bps in 2019.
  • Quarter analysis of 4 years shows Arbutus Biopharma's Return on Invested Capital stood at 0.23% in 2018, then plummeted by -634bps to 1.7% in 2019, then fell by -1bps to 1.72% in 2020, then surged by 71bps to 0.5% in 2022.
  • Its Return on Invested Capital stands at 0.5% for Q4 2022, versus 0.46% for Q3 2022 and 0.43% for Q2 2022.